The Combination of NLR and D-dimer as Predictor Instrument for the Severity of COVID-19

Shofia Widya Murti, D. Prihatni, A. Sugianli
{"title":"The Combination of NLR and D-dimer as Predictor Instrument for the Severity of COVID-19","authors":"Shofia Widya Murti, D. Prihatni, A. Sugianli","doi":"10.24293/ijcpml.v28i3.1998","DOIUrl":null,"url":null,"abstract":"Coronavirus Disease-19 (COVID-19) is caused by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2). In severe cases, the immune response may cause a cytokine storm. Neutrophil Lymphocyte Ratio (NLR) and D-dimer are parameters that may be used to predict the severity of COVID-19. This study aims to determine the diagnostic validity of the combination of NLR and D-dimer on the severity of COVID-19 patients. The study population was hospitalized COVID-19 patients whose diagnosis were confirmed by real time-PCR. This was a retrospective cross-sectional study. The cut-off value was based on the Area Under Curve (AUC) of the Receiver Operator Characteristic Curve (ROC) analysis and the combination of NLR and D-Dimer validity was tested against the severe and non-severe COVID-19 groups by assessing sensitivity, specificity, Positive Predictive Value (PPV), Negative Predictive Value (NPV), positive Likelihood Ratio (LR+) and negative Likelihood Ratio (LR-). There were 1,314 subjects. Seven hundred and forty-four were in the severe group, 570 in the non-severe group. The combination of NLR > 4.02 and D-dimer > 1.12 mg/L on the severity of COVID-19 showed a sensitivity value of 70.8%, specificity 98.3%, PPV 98.1%, NPV 72.1%, LR+ 40.38 and LR- 0.30. The combination of NLR >4.02 and D-dimer >1.12 mg/L for the severity of COVID-19 showed high specificity and PPV (98.3% and 98.1%). This was also supported by the LR+ value, which indicates that if NLR > 4.02 and D-dimer > 1.12 mg/L, it may cause severe COVID-19 by 40.38 times compared to NLR ≤4.02, and D-dimer ≤1.12 mg/L. The combination of NLR and D-Dimer can be used to predict the severity of COVID-19.","PeriodicalId":354500,"journal":{"name":"Indonesian Journal of Clinical Pathology and Medical Laboratory","volume":"106 5 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indonesian Journal of Clinical Pathology and Medical Laboratory","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24293/ijcpml.v28i3.1998","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Coronavirus Disease-19 (COVID-19) is caused by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2). In severe cases, the immune response may cause a cytokine storm. Neutrophil Lymphocyte Ratio (NLR) and D-dimer are parameters that may be used to predict the severity of COVID-19. This study aims to determine the diagnostic validity of the combination of NLR and D-dimer on the severity of COVID-19 patients. The study population was hospitalized COVID-19 patients whose diagnosis were confirmed by real time-PCR. This was a retrospective cross-sectional study. The cut-off value was based on the Area Under Curve (AUC) of the Receiver Operator Characteristic Curve (ROC) analysis and the combination of NLR and D-Dimer validity was tested against the severe and non-severe COVID-19 groups by assessing sensitivity, specificity, Positive Predictive Value (PPV), Negative Predictive Value (NPV), positive Likelihood Ratio (LR+) and negative Likelihood Ratio (LR-). There were 1,314 subjects. Seven hundred and forty-four were in the severe group, 570 in the non-severe group. The combination of NLR > 4.02 and D-dimer > 1.12 mg/L on the severity of COVID-19 showed a sensitivity value of 70.8%, specificity 98.3%, PPV 98.1%, NPV 72.1%, LR+ 40.38 and LR- 0.30. The combination of NLR >4.02 and D-dimer >1.12 mg/L for the severity of COVID-19 showed high specificity and PPV (98.3% and 98.1%). This was also supported by the LR+ value, which indicates that if NLR > 4.02 and D-dimer > 1.12 mg/L, it may cause severe COVID-19 by 40.38 times compared to NLR ≤4.02, and D-dimer ≤1.12 mg/L. The combination of NLR and D-Dimer can be used to predict the severity of COVID-19.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
NLR和d -二聚体联合作为COVID-19严重程度的预测工具
冠状病毒病-19 (COVID-19)是由严重急性呼吸综合征-冠状病毒-2 (SARS-CoV-2)引起的。在严重的情况下,免疫反应可能引起细胞因子风暴。中性粒细胞淋巴细胞比率(NLR)和d -二聚体是可用于预测COVID-19严重程度的参数。本研究旨在确定NLR联合d -二聚体对COVID-19患者严重程度的诊断有效性。研究人群为实时荧光定量pcr确诊的住院COVID-19患者。这是一项回顾性横断面研究。截断值基于受试者算子特征曲线(ROC)分析的曲线下面积(AUC),并通过评估敏感性、特异性、阳性预测值(PPV)、阴性预测值(NPV)、阳性似然比(LR+)和阴性似然比(LR-),对重症和非重症COVID-19组进行NLR和d -二聚体联合效度检验。共有1314名受试者。744人在严重组,570人在非严重组。NLR > 4.02和d -二聚体> 1.12 mg/L对COVID-19严重程度的敏感性值为70.8%,特异性值为98.3%,PPV为98.1%,NPV为72.1%,LR+ 40.38和LR- 0.30。NLR >4.02和d -二聚体>1.12 mg/L对COVID-19严重程度的特异性和PPV均较高(分别为98.3%和98.1%)。LR+值也支持了这一点,即NLR > 4.02, d -二聚体> 1.12 mg/L时,与NLR ≥4.02,d -二聚体≥1.12 mg/L相比,可能导致严重COVID-19的几率是NLR的40.38倍。NLR与d -二聚体联合可用于预测COVID-19的严重程度。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Comparison of Lateral-flow Nanoparticle Fluorescence Assay and ELISA Method for Interferon-y Release Assay Test Correlation between VCAM-1 Level and Absolute Monocyte Count in Coronary Artery Disease Performance Evaluation of Semi-quantitative Urine Albumin Creatinine Ratio Using Meditape UC-11A Strip Test Risk Factors of Fungal Growth in Sputum Culture from Severe and Critical COVID-19 Patients Analysis of Albumin to Globulin Ratio as A Prognostic Predictor in Lupus Nephritis Patients
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1